[email protected]
CAS 148407-07-2 Uridine 5′-diphospho-galuronic acid trisodium molecular structure lightbox
CAS RN: 148407-07-2

Uridine 5′-diphospho-galuronic acid trisodium

Product Availability

Choose a grade to view its available package options.

3 package records1 with current stock2 grade groups
Batch No.PackageAvailabilityWarehouseLead TimeInquiry
Batchno.20251031 10mg In stock Shanghai Inquiry
Batchno.20260119 50mg Out of stock 8-10 business days Inquiry
Batch No.PackageAvailabilityWarehouseLead TimeInquiry
Batchno.20250517 10mg / 50mg Out of stock 5-7 business days Inquiry
  • Product code: starshine_CAS148407-07-2
  • Purity/Analytical Methods: >99.0%
GET A QUOTE

148407-07-2 / trisodium;(2S,3R,4S,5R,6R)-6-[[[(2R,3S,4R,5R)-5-(2,4-dioxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-oxidophosphoryl]oxy-oxidophosphoryl]oxy-3,4,5-trihydroxyoxane-2-carboxylate

Standard CAS: 148407-07-2 Multi CAS: No
Basic Information Computed Properties Safety & Transport

Basic Information

CAS
148407-07-2
Multi CAS
No
Molecular Formula
C15H19N2Na3O18P2
Molecular Weight
646.230000
Exact Mass
645.980119
SMILES
C1=CN(C(=O)NC1=O)[C@H]2[C@@H]([C@@H]([C@H](O2)COP(=O)([O-])OP(=O)([O-])O[C@@H]3[C@@H]([C@H]([C@H]([C@H](O3)C(=O)[O-])O)O)O)O)O.[Na+].[Na+].[Na+]
InChI
InChI=1S/C15H22N2O18P2.3Na/c18-5-1-2-17(15(26)16-5)12-9(22)6(19)4(32-12)3-31-36(27,28)35-37(29,30)34-14-10(23)7(20)8(21)11(33-14)13(24)25;;;/h1-2,4,6-12,14,19-23H,3H2,(H,24,25)(H,27,28)(H,29,30)(H,16,18,26);;;/q;3*+1/p-3/t4-,6-,7+,8-,9-,10-,11+,12-,14-;;;/m1.../s1
InChIKey
XXXUNWUNTOMVIG-DSWQXYTCSA-K

Computed Properties

Structural Parameters

Heavy atom count
40
Aromatic heavy atom count
6
Fraction Csp3
0.67
Rotatable bonds
9
H-bond acceptors
19
H-bond donors
6
Molar refractivity
102.27
TPSA
322.55

LogP / Solubility

WLOGP
-16.29
MLOGP
-14.28
XLogP3
-16.29
Consensus LogP
-15.62
Log S (ESOL)
6.9
Class (ESOL)
Highly soluble
Log S (Ali)
6.9
Class (Ali)
Highly soluble
Log S (SILICOS-IT)
8.58
Class (SILICOS-IT)
Highly soluble

ADME

GI absorption
Low
BBB permeant
No
P-gp substrate
Yes
CYP1A2 inhibitor
No
CYP2C19 inhibitor
No
CYP2C9 inhibitor
No
CYP2D6 inhibitor
No
CYP3A4 inhibitor
No
Log Kp (skin permeation)
-18.23

Drug-likeness / Medicinal Chemistry

Lipinski
No
Ghose
No
Veber
No
Egan
No
Muegge
No
Bioavailability score
0.17
Brenk alerts
1
Leadlikeness
No
Synthetic Accessibility
9.5

Safety & Transport

Pictogram(s)
Acute Toxic
Signal
Danger
GHS Hazard Statements
H301 (100%): Toxic if swallowed [Danger Acute toxicity, oral] H311 (100%): Toxic in contact with skin [Danger Acute toxicity, dermal] H315 (100%): Causes skin irritation [Warning Skin corrosion/irritation] H319 (100%): Causes serious eye irritation [Warning Serious eye damage/eye irritation] H331 (100%): Toxic if inhaled [Danger Acute toxicity, inhalation]
Precautionary Statement Codes
P261, P262, P264, P264+P265, P270, P271, P280, P301+P316, P302+P352, P304+P340, P305+P351+P338, P316, P319, P321, P330, P332+P317, P337+P317, P361+P364, P362+P364, P403+P233, P405, and P501

Customers Also Viewed

Get In Touch

Contact Us